Tafenoquine plus chloroquine for the treatment and relapse prevention of Plasmodium vivax malaria (DETECTIVE): a multicentre, double-blind, randomised, phase 2b dose-selection study-Reference-Cited by-同舟云学术

Tafenoquine plus chloroquine for the treatment and relapse prevention of Plasmodium vivax malaria (DETECTIVE): a multicentre, double-blind, randomised, phase 2b dose-selection study

Published:2014-03 Issue:9922 Volume:383 Page:1049-1058
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Llanos-Cuentas Alejandro,Lacerda Marcus V,Rueangweerayut Ronnatrai,Krudsood Srivicha,Gupta Sandeep K,Kochar Sanjay K,Arthur Preetam,Chuenchom Nuttagarn,Möhrle Jörg J,Duparc Stephan,Ugwuegbulam Cletus,Kleim Jörg-Peter,Carter Nick,Green Justin A,Kellam Lynda

Publisher

Elsevier BV

Subject

General Medicine

Reference23 articles.

1. Vivax malaria: neglected and not benign;Price;Am J Trop Med Hyg,2007

2. The neglected burden of Plasmodium vivax malaria;Mendis;Am J Trop Med Hyg,2001

3. The anaemia of Plasmodium vivax malaria;Douglas;Malar J,2012

4. The global public health significance of Plasmodium vivax;Battle;Adv Parasitol,2012

5. Targeting the hypnozoite reservoir of Plasmodium vivax: the hidden obstacle to malaria elimination;Wells;Trends Parasitol,2010

Cited by 208 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tafenoquine for Relapsing Babesiosis: A Case Series;Clinical Infectious Diseases;2024-05-30

2. Optimal balance of benefit versus risk for tafenoquine in the treatment of Plasmodium vivax malaria;Malaria Journal;2024-05-13

3. Methaemoglobin as a surrogate marker of primaquine antihypnozoite activity inPlasmodium vivaxmalaria: a systematic review and individual patient data meta-analysis;2024-05-08

4. Comment on 'The clinical pharmacology of tafenoquine in the radical cure of Plasmodium vivax malaria: An individual patient data meta-analysis';eLife;2024-02-07

5. Primaquine dose and the risk of haemolysis in patients with uncomplicated Plasmodium vivax malaria: a systematic review and individual patient data meta-analysis;The Lancet Infectious Diseases;2024-02